The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective longitudinal evaluation of microbiome diversity in patients with hematological malignancy undergoing allogeneic hematopoietic stem cell transplantation (HSCT).
 
Emily Walsh
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
Research Funding - Seres Therapeutics (Inst)
 
Anastasia Tsakmaklis
Research Funding - Seres Therapeutics
 
Liyang Diao
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Remix Therapeutics (I); Seres Therapeutics
Consulting or Advisory Role - Arrakis Therapeutics (I)
Research Funding - Seres Therapeutics
Patents, Royalties, Other Intellectual Property - IP related to Seres research in programs SER-109, SER-287, SER-301, SER-155
Travel, Accommodations, Expenses - Seres Therapeutics
 
Jessica Bryant
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
Research Funding - Seres Therapeutics
 
Mary-Jane Lombardo
Employment - Prolacta Bioscience (I); Seres Therapeutics
 
Barbara McGovern
Employment - Seres Therapeutics
Leadership - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
Research Funding - Seres Therapeutics
 
Lisa von Moltke
Employment - Seres Therapeutics
Leadership - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Matthew R. Henn
Employment - Seres Therapeutics
Leadership - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
Patents, Royalties, Other Intellectual Property - Seres Therapeutics
 
Christopher B. Ford
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Maria J.G.T. Vehreschild
Consulting or Advisory Role - Astellas Pharma; bioMérieux; Farmak International Holding GmbH; Ferring; Immunic; MaaT Pharma; Merck; Roche; SocraTec
Speakers' Bureau - Astellas Pharma; Ferring; Gilead Sciences; Merck; Pfizer
Research Funding - 3M; Astellas Pharma; BioNTech; Da Volterra; Evonik Industries; Gilead Sciences; Glycom; Immunic; MaaT Pharma; Merck; Organobalance; Seres Therapeutics; Takeda